Skip to content
  • Drug companies aren’t making new antibiotics. Is there an economic cure?

    PBS NewsHour - 08/04/2017

    As drug-resistant infections proliferate, financial barriers are preventing the pharmaceutical industry from investing in new drugs to fight off superbugs. Economics correspondent Paul Solman, in a series of reports with science correspondent Miles O’Brien, explores how researchers, including Northeastern professor Slava Epstein, could be incentivized to develop new antibiotics.

  • Cookies on Northeastern sites

    This website uses cookies and similar technologies to understand your use of our website and give you a better experience. By continuing to use the site or closing this banner without changing your cookie settings, you agree to our use of cookies and other technologies. To find out more about our use of cookies and how to change your settings, please go to our Privacy Statement.